Screening for Fabry disease in male patients with end-stage renal disease in western France.

Vigneau, C; Germain, D P; Larmet, D; Jabbour, F; Hourmant, M

Vigneau, C; Germain, D P; Larmet, D; Jabbour, F; Hourmant, M.

Affiliation

Vigneau C; Inserm, EHESP, IRSET, UMR_S 1085, University of Rennes, CHU de Rennes, 35000 Rennes, France.
Germain DP; Inserm, EHESP, IRSET, UMR_S 1085, University of Rennes, CHU de Rennes, 35000 Rennes, France; French Referral Center for Fabry disease, Division of Medical Genetics, AP-HP Paris Saclay University, University of Versailles, 2, avenue de la source de la Bièvre, 78180 Montigny, France; Second Department
Larmet D; Department of Nephrology, University of Nantes, 44093 Nantes cedex 01, France.
Jabbour F; French Referral Center for Fabry disease, Division of Medical Genetics, AP-HP Paris Saclay University, University of Versailles, 2, avenue de la source de la Bièvre, 78180 Montigny, France.
Hourmant M; Department of Nephrology, University of Nantes, 44093 Nantes cedex 01, France.

Nephrol Ther ; 17(3): 180-184, 2021 Jun.

Article in En | MEDLINE | ID: mdl-33994139

Subject(s)

Fabry Disease; Kidney Failure, Chronic; Fabry Disease/complications; Fabry Disease/diagnosis; Fabry Disease/epidemiology; Humans; Kidney Failure, Chronic/diagnosis; Kidney Failure, Chronic/epidemiology; Kidney Failure, Chronic/etiology; Male; Prospective Studies; Renal Dialysis; alpha-Galactosidase/genetics

Key words

Dialysis; Dried blood spot; End-stage renal disease; Fabry disease; Transplantation

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fabry Disease / Kidney Failure, Chronic Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Humans / Male Language: En Journal: Nephrol Ther Journal subject: NEFROLOGIA / TERAPEUTICA Year: 2021 Type: Article Affiliation country: France

Fulltext

XML

PubMed Links

Search on Google